上海金畔生物科技有限公司为生命科学和医药研发人员提供生物活性分子抑制剂、激动剂、特异性抑制剂、化合物库、重组蛋白，专注于信号通路和疾病研究领域。
Ipilimumab (Synonyms: 伊匹木单抗; MDX-010; BMS-734016) 纯度: 99.88%
Ipilimumab 是一种全人类单克隆抗体 IgG1κ，能够抗 CTLA-4（一种由活化的 T 细胞产生的免疫抑制分子）。
Ipilimumab Chemical Structure
CAS No. : 477202-00-9
| 规格 | 价格 | 是否有货 | 数量 |
|---|---|---|---|
| 1 mg | ￥5500 | In-stock | |
| 5 mg | 询价 | ||
| 25 mg | 询价 | ||
| 50 mg | 询价 |
* Please select Quantity before adding items.
| 生物活性 |
Ipilimumab is a fully human monoclonal IgG1κ antibody against the cytotoxic T-lymphocyte antigen-4 (CTLA-4), an immune-inhibitory molecule expressed in activated T cells and in suppressor T regulatory cells. |
|---|---|
| 体外研究 (In Vitro) |
Ipilimumab inhibits CTLA-4, allowing the T cell immune response to be reactivated against tumor cells. Ipilimumab can promote antitumor activity as a single agent or in combination with cytokines, chemotherapy, or vaccines[1]. 上海金畔生物科技有限公司 has not independently confirmed the accuracy of these methods. They are for reference only. |
| Clinical Trial |
|
| 分子量 |
145313.36 |
| CAS 号 |
477202-00-9 |
| 中文名称 |
易普利姆玛；伊匹单抗；伊匹木单抗 |
| 储存方式 |
Please store the product under the recommended conditions in the Certificate of Analysis. |
| 参考文献 |
|
所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务